ES529225A0 - Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex. - Google Patents

Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.

Info

Publication number
ES529225A0
ES529225A0 ES529225A ES529225A ES529225A0 ES 529225 A0 ES529225 A0 ES 529225A0 ES 529225 A ES529225 A ES 529225A ES 529225 A ES529225 A ES 529225A ES 529225 A0 ES529225 A0 ES 529225A0
Authority
ES
Spain
Prior art keywords
plipeptide
immunoreactive
determinant
antigen
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529225A
Other languages
English (en)
Other versions
ES8505253A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MGI Pharma Inc
Original Assignee
Molecular Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES529225(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/400,028 external-priority patent/US4818694A/en
Priority claimed from US06/510,551 external-priority patent/US4891315A/en
Application filed by Molecular Genetics Inc filed Critical Molecular Genetics Inc
Publication of ES8505253A1 publication Critical patent/ES8505253A1/es
Publication of ES529225A0 publication Critical patent/ES529225A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES529225A 1982-07-20 1984-01-27 Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex. Granted ES529225A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/400,028 US4818694A (en) 1982-07-20 1982-07-20 Production of herpes simplex viral protein
US43636882A 1982-10-25 1982-10-25
US06/510,551 US4891315A (en) 1982-10-25 1983-07-06 Production of herpes simplex viral porteins

Publications (2)

Publication Number Publication Date
ES8505253A1 ES8505253A1 (es) 1985-05-16
ES529225A0 true ES529225A0 (es) 1985-05-16

Family

ID=27410368

Family Applications (2)

Application Number Title Priority Date Filing Date
ES524245A Expired ES8504254A1 (es) 1982-07-20 1983-07-19 Procedimiento para obtener un polipeptido
ES529225A Granted ES529225A0 (es) 1982-07-20 1984-01-27 Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES524245A Expired ES8504254A1 (es) 1982-07-20 1983-07-19 Procedimiento para obtener un polipeptido

Country Status (14)

Country Link
EP (1) EP0101655B1 (es)
CA (1) CA1295561C (es)
DE (1) DE3382072D1 (es)
DK (1) DK333183A (es)
ES (2) ES8504254A1 (es)
FI (1) FI83974C (es)
GR (1) GR78647B (es)
IE (1) IE56902B1 (es)
IL (1) IL69269A (es)
NO (1) NO172855C (es)
NZ (1) NZ204948A (es)
PH (1) PH21239A (es)
PL (1) PL150654B1 (es)
PT (1) PT77014B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
EP0133063B1 (en) * 1983-06-23 1987-01-07 Stanley Dr. Person Immunologically reactive non-glycosylated amino acid chains of glycoprotein b of herpes virus types 1 and 2
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS615786A (ja) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst 単純ヘルペスウイルス遺伝子を組込んだ組換えｄｎａ、形質転換動物細胞および単純ヘルペスウイルス蛋白質の製法
DE3582200D1 (de) * 1984-07-20 1991-04-25 Chemo Sero Therapeut Res Inst Rekombinante dns, enthaltend ein herpes-simplex-virus-gen oder ein fragment davon, hefe transformiert mit dieser rekombinanten dns und verfahren zur herstellung von herpes-simplex-virus-proteinen.
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
US5149532A (en) * 1989-11-01 1992-09-22 Cedars Sinai Medical Center Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
US8541002B2 (en) 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
AU2015225499B2 (en) * 2014-03-03 2020-05-14 Albert Einstein College Of Medicine, Inc. Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens

Also Published As

Publication number Publication date
PT77014B (en) 1986-01-24
NZ204948A (en) 1987-10-30
ES8505253A1 (es) 1985-05-16
FI832632A0 (fi) 1983-07-19
ES524245A0 (es) 1985-04-01
DK333183D0 (da) 1983-07-19
PL243134A1 (en) 1984-08-13
EP0101655A2 (en) 1984-02-29
DE3382072D1 (de) 1991-02-07
FI83974C (fi) 1991-09-25
GR78647B (es) 1984-09-27
EP0101655B1 (en) 1991-01-02
DK333183A (da) 1984-01-21
NO172855B (no) 1993-06-07
PT77014A (en) 1983-08-01
EP0101655A3 (en) 1985-12-18
NO832626L (no) 1984-01-23
ES8504254A1 (es) 1985-04-01
CA1295561C (en) 1992-02-11
FI83974B (fi) 1991-06-14
PL150654B1 (en) 1990-06-30
PH21239A (en) 1987-08-21
IL69269A0 (en) 1983-11-30
FI832632A (fi) 1984-01-21
NO172855C (no) 1993-09-15
IE831690L (en) 1984-01-20
IE56902B1 (en) 1992-01-29
IL69269A (en) 1989-12-15

Similar Documents

Publication Publication Date Title
PH25689A (en) Materials, methods for herpes simplex virus vaccination
ES529225A0 (es) Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.
ZA929355B (en) Expression of specific immunogens using viral antigens.
DE3266201D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain
ES528000A0 (es) Un procedimiento para la purificacion de un antigeno.
ES524942A0 (es) Procedimiento para la preparacion de un plasmido recombinante insertado con el gen del virus de la hepatitis b.
AU580059B2 (en) Vaccine against rabies and preparation process thereof
ES527056A0 (es) Un procedimiento para preparar una cepa mejorada de c. acetobutylicum
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
ES520275A0 (es) Procedimiento para preparar poliamidas resistentes al impacto. otrosi
EP0198828A4 (en) VACCINE AGAINST THE VIRUSES OF INFECTIOUS BURSAL DISEASE.
ES522899A0 (es) "un procedimiento para preparar un fragmento de adn".
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
WO1988007080A3 (en) Transgenic animal cells resistant to viral infection
DK448687A (da) Dna, der koder for et virusantigen
ES546115A0 (es) Un procedimiento para preparar una molecula de adn recombinante.
EP0119259A4 (en) NOT A, NOT B, HEPATITIS VIRUS, METHOD FOR DETERMINATION, CLEANING, LABELING, DIAGNOSIS AND IMMUNIZATION.
ES536924A0 (es) Un procedimiento para producir anticuerpos monoclonales especificos frente al virus pvy
GB8412158D0 (en) Recombinant dna derived antigens
AU553932B2 (en) Vaccine against herpes virus vaccine
AU3748785A (en) Infectious bursal disease virus vaccine
IE830034L (en) Bluetongue virus vaccine.
ATE59679T1 (de) Herstellung von herpes-simplex-virusproteinen.
ES517531A0 (es) Procedimiento para elaborar vino de mosto de uva.
ES536923A0 (es) Un procedimiento para producir anticuerpos monoclonales especificos frente al virus ctv

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980302